BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 34956201)

  • 1. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
    Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
    Front Immunol; 2021; 12():773570. PubMed ID: 34956201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles and mechanism of m
    Chen L; He Y; Zhu J; Zhao S; Qi S; Chen X; Zhang H; Ni Z; Zhou Y; Chen G; Liu S; Xie T
    Biomed Pharmacother; 2023 Jul; 163():114839. PubMed ID: 37156113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
    Ouyang X; Gong Y
    Front Immunol; 2022; 13():912526. PubMed ID: 35720276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N
    Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
    Front Immunol; 2021; 12():697026. PubMed ID: 34526985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.
    Chen Z; Hu Y; Jin L; Yang F; Ding H; Zhang L; Li L; Pan T
    Front Pharmacol; 2022; 13():873030. PubMed ID: 35462896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of RNA methylation by means of N
    Wang S; Sun C; Li J; Zhang E; Ma Z; Xu W; Li H; Qiu M; Xu Y; Xia W; Xu L; Yin R
    Cancer Lett; 2017 Nov; 408():112-120. PubMed ID: 28867248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of N6-methyladenosine (m
    Elsabbagh RA; Rady M; Watzl C; Abou-Aisha K; Gad MZ
    Cell Commun Signal; 2022 Sep; 20(1):140. PubMed ID: 36085064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer.
    Wu W; Zhang F; Zhao J; He P; Li Y
    Exp Cell Res; 2022 Jun; 415(2):113115. PubMed ID: 35341774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma.
    Chen F; Xie X; Chao M; Cao H; Wang L
    Front Immunol; 2022; 13():917153. PubMed ID: 35711459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and evolution of RNA N6-methyladenosine modification.
    Zhu ZM; Huo FC; Pei DS
    Int J Biol Sci; 2020; 16(11):1929-1940. PubMed ID: 32398960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions.
    Imam H; Kim GW; Siddiqui A
    Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
    Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
    Front Immunol; 2022; 13():819080. PubMed ID: 35359993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of m
    Chen XY; Zhang J; Zhu JS
    Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Cao X; Geng Q; Fan D; Wang Q; Wang X; Zhang M; Zhao L; Jiao Y; Deng T; Liu H; Zhou J; Jia L; Xiao C
    Mol Cancer; 2023 Mar; 22(1):42. PubMed ID: 36859310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions of RNA N6-methyladenosine modification in cancer progression.
    Chen B; Li Y; Song R; Xue C; Xu F
    Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA N6-methyladenosine methylation and skin diseases.
    Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
    Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.